Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001440062 | SCV001642965 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2023-06-05 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001664880 | SCV001880245 | uncertain significance | not provided | 2020-12-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003985497 | SCV004713061 | likely benign | CACNA1A-related disorder | 2021-12-30 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |